Cost-utility Analysis Treatment of Bartholin's Abscess : Word Catheter Versus Incision-drainage. (BARTHO-KT)

June 5, 2023 updated by: Nantes University Hospital
Bartholin's gland abscess is a condition requiring emergency consultation. Placement of a Word catheter, which is a minor technique used in France as a treatment of bartholin's Abscess, can be done in an emergency room without hospitalization. Actually, incision-drainage, which is the most widespread treatment in France, is performed on day surgery with or without overnight hospitalization. Our hypothesis is that the use of Word catheter compared to incision-drainage would not modify the quality of life of the patients but would allow a saving of up to 3 M€ per year in France.

Study Overview

Status

Active, not recruiting

Study Type

Interventional

Enrollment (Actual)

302

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France
        • Chu Angers
      • Bordeaux, France
        • Bordeaux University Hospital
      • Caen, France
        • CHU Caen
      • Clamart, France
        • Ch Antoine Beclere
      • Clermont-Ferrand, France
        • CHU Estaing
      • Levallois-Perret, France
        • Institut Franco Britannique
      • Lille, France
        • Chu Lille
      • Nancy, France
        • Nancy University Hospital
      • Nantes, France
        • Chu Nantes
      • Nîmes, France
        • CHU Caremeau
      • Paris, France
        • CHU Cochin
      • Paris, France
        • CHU Robert Debré
      • Paris, France
        • Ch Kremlin Bicetre
      • Poissy, France
        • Chi Poissy
      • Poitiers, France
        • CHU Poitiers
      • Rennes, France
        • Rennes University Hospital
      • Toulouse, France
        • Chu Toulouse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Abscess of Bartholin's gland Patient able to understand the protocol Patient who signed informed consent Patient with social insurance

Exclusion Criteria:

Spontaneous fistulization of the abscess before surgical treatment Abscess volume under 3 ml Medical treatment which avoid incision or word catheter placement patients under guardianship Unable to complete questionnaires Patients not affiliated to social protection regimen Pregnant or post-partum women (until 4 weeks after delivery)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Word catheter
The abscess is incised and the Word catheter is inserted into the residual cavity to create a neo-channel to prevent recurrence. The catheter is removed after 4 weeks during a consultation
Use of the Word catheter to remove the Bartholin's abscess
Active Comparator: Incision-drainage
This procedure performed under general or loco-regional anaesthesia consists in incising the abscess, draining the pus build-up and placing a wick in the residual cavity to promote progressive healing from the inside out.
Incision-drainage to remove the Bartholin's abscess

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cost-utility ratio, according to the societal perspective of the of the management of Bartholin's gland abscess by the Word catheter compared to the incision-drainage
Time Frame: 12 months

The utility will be measured by:

Quality Adjusted Life Year (QALYs) as estimated from responses to the Euroqol-5 Dimensions (EQ-5D 5L) health-related quality of life questionnaire. The questionnaire focuses on 5 dimensions: mobility, personal autonomy, current activities, pain/discomfort and anxiety/depression. For each of these dimensions, 5 answers are possible.

The costs will be measured by the addition of the following costs:

Outpatient resource consumption collected in a declarative patient questionnaire. Hospital care resources using the the database of the Medicalised Information System Program of each recruiting site

12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Budget impact analysis for the health insurance point of view in case of diffusion of the Word catheter
Time Frame: 5 years
Comparison of intervention costs on the study sample and projection of these costs over 5 years, from the health insurance and hospital perspectives
5 years
Non inferiority evaluation of Word catheter vs. Incision drainage in terms of pain
Time Frame: at baseline and day 1
Pain numeric scale from 0 to 10
at baseline and day 1
Non inferiority evaluation of Word catheter versus incision-drainage in terms of recurrence rate
Time Frame: 12 months
Number of homolateral recurrences of Bartholin's abscess, declared by the patient
12 months
Comparison of Word catheter versus incision-drainage concerning pain
Time Frame: 12 months
Pain numeric scale from 0 to 10
12 months
Comparison of Word catheter versus incision-drainage concerning management time
Time Frame: Day 0 (procedure day), Day 1
Date and time of patient initial management (randomization) Date and time of the beginning of the procedure date and time of the end of the procedure date and time of the hospital departure
Day 0 (procedure day), Day 1
Comparison of Word catheter versus incision-drainage in terms of complications
Time Frame: 12 months
number of complications related to the procedure (healing complications, infection, lost of the Word catheter), contro-lateral Bartholin's abscess occurrence
12 months
Comparison of Word catheter versus incision-drainage in terms of surgical failure
Time Frame: Immediate post-operative (D0) and one month
Word catheter: insertion failure, loss, removal decision (from the patient or the surgeon) Incision-drainage: incomplete drainage
Immediate post-operative (D0) and one month
Comparison of Word catheter versus incision-drainage in terms of impact on sexual activity
Time Frame: Baseline, one month, 6 months and 12 months
Score of the Female Sexual Function Index: self-questionnaire including 19 questions assessing different parameters of the sexual activity
Baseline, one month, 6 months and 12 months
Comparison of Word catheter versus incision-drainage in terms of quality of life using the SF-12-HS
Time Frame: Baseline, one month, 6 months and 12 months
Short-Form-12-Health-Survey questionnaire score: self-questionnaire including 12 questions measuring different aspects of quality of life
Baseline, one month, 6 months and 12 months
Comparison of Word catheter versus incision-drainage in terms of quality of life using the EQ-5D
Time Frame: Baseline, one day, one month, 3 months, 6 months, 9 months and 12 months
EQ-5D 5L score (described in primary outcome)
Baseline, one day, one month, 3 months, 6 months, 9 months and 12 months
Comparison of Word catheter versus incision-drainage in terms global patient impression and improvement
Time Frame: One day, one month, 3 months, 6 months, 9 months and 12 months
Patient Global Impression and Improvement (PGI-I) global index used to rate the response of a condition to a therapy (transition scale). It is a single question asking the patient to rate their global condition now, as compared with how it was prior to before beginning treatment on a scale from 1 - very much better to 7 - very much worse
One day, one month, 3 months, 6 months, 9 months and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thibault Thubert, PhD, CHU de Nantes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2020

Primary Completion (Estimated)

May 31, 2024

Study Completion (Estimated)

May 31, 2024

Study Registration Dates

First Submitted

September 16, 2019

First Submitted That Met QC Criteria

September 16, 2019

First Posted (Actual)

September 18, 2019

Study Record Updates

Last Update Posted (Actual)

June 6, 2023

Last Update Submitted That Met QC Criteria

June 5, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bartholin's Gland Abscess Treatment

Clinical Trials on Word Catheter

Subscribe